Effectiveness across severe asthma biologic classes (Anti-IL-5 vs Anti IgE) in patients eligible for both (FIRE)

First published 18/11/2020

Last updated 23/04/2024

EU PAS number:

EUPAS38128

Study

Finalised

Documents

Study protocol

Initial protocol

ISAR_OPCG1903_Effectiveness across Bx classes_Protocol 13 Aug 2020

English (351.33 KB - PDF)View document

Study results

Study report

Other information

ENCePP Seal

ENCePP Seal documents

Conflicts of interest of investigators

200730_COI_David Price_V8

English (47.99 KB - PDF)View document

Composition of steering group and observers

Effectiveness Across Bx Classes_Steering Committee

English (11.46 KB - PDF)View document

Secondary tabs